Purchase Order 36C24226P0038

Award Date 10/3/25
Potential Completion Date 11/2/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15205, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the supply of TARPEYO 4MG, a prescription medication, to the New York Harbor VA Medical Center. The contract has a ceiling value of $10,896.98 and an ultimate completion date of June 23, 2025. The contract does...
This is a federal contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the purchase of TARPEYO 4MG for the New York Harbor, with an ultimate completion date of November 5, 2025 and a ceiling value of $10,896.98. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Pantherx Specialty, LLC is the...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian federal agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency provision of TARPEYO 4mg prescription medication, with a ceiling value of $10,896.98 and a performance period ending on November 2, 2025. The contract was awarded on October 2, 2025, and does not have a set-aside...
This is a federal contract award from the Veterans Integrated Service Network (VISN) 2, a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency procurement of TARPEYO 4mg prescription medication for the New York Harbor region. The contract is a firm fixed-price purchase order with a ceiling value of $10,896.98 and a period of performance ending on August 16, 2025. Pantherx Specialty is the prime...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the supply of TARPEYO 4MG, a specialized pharmaceutical product, to the VA's New York Harbor healthcare system. The contract has a ceiling value of $10,896.98 and a period of performance through July 31, 2025. The contract does not have a set-aside designation. Pantherx...
The U.S. Department of Veterans Affairs (VA) awarded a $10,896.98 firm fixed-price purchase order contract to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the provision of TARPEYO 4MG NDC 81749-0004-01, an emergency medication. The contract has an ultimate completion date of August 22, 2025 and was awarded on August 15, 2025. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialized pharmacy that focuses on...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is for the supply of the prescription medication Tarpeyo 4mg capsules to VA facilities within Veterans Integrated Service Network 2. The contract has a total ceiling value of $10,638.00 and runs through March 20, 2025. There is no set-aside designation associated...
This federal contract award is for the supply of TARPEYO 4MG drug prescriptions to the New York Harbor Healthcare System, a division of the Department of Veterans Affairs (VA). The $10,897.20 firm fixed price purchase order was awarded to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. Pantherx Specialty is a specialized pharmacy focused on rare diseases and customized medications, and has established itself as a targeted provider of...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy, to provide the pharmaceutical product Ruzurgi [amifampridine] to Veterans Integrated Service Network 16 facilities. The contract has a potential value of $119,339.01 and a completion date of September 30, 2020. Pantherx Specialty is a subsidiary of Centene Corporation that operates as a specialty pharmacy focused...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 to Pantherx Specialty, LLC, a subsidiary of Centene Corporation, to provide the drug Ruzurgi 10mg. The contract has a ceiling value of $85,242.15 and an ultimate completion date of February 13, 2022. No set-aside designation was used for this award. Pantherx Specialty, a specialty pharmacy focused on rare diseases, has received multiple federal contracts from the...

This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network (VISN) 2 to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the provision of TARPEYO 4MG for the New York Harbor, Margaret Cochran Corbin VAMC, with a ceiling value of $10,896.98 and a period of performance through November 2, 2025. The contract was awarded on October 3, 2025, and does not have a set-aside designation. Pantherx Specialty, LLC is the prime contractor on this award, which supports the medical needs of veterans by providing specialized pharmaceutical products to the Department of Veterans Affairs healthcare system.

Generated 10/12/25, 1:04 AM